RYAAY

63.53

-0.35%↓

KNEBV.FI

53.58

-0.11%↓

MTX1

376.6

-0.63%↓

WRT1V.FI

24.37

+1.58%↑

BVI

26.84

+0.9%↑

RYAAY

63.53

-0.35%↓

KNEBV.FI

53.58

-0.11%↓

MTX1

376.6

-0.63%↓

WRT1V.FI

24.37

+1.58%↑

BVI

26.84

+0.9%↑

RYAAY

63.53

-0.35%↓

KNEBV.FI

53.58

-0.11%↓

MTX1

376.6

-0.63%↓

WRT1V.FI

24.37

+1.58%↑

BVI

26.84

+0.9%↑

RYAAY

63.53

-0.35%↓

KNEBV.FI

53.58

-0.11%↓

MTX1

376.6

-0.63%↓

WRT1V.FI

24.37

+1.58%↑

BVI

26.84

+0.9%↑

RYAAY

63.53

-0.35%↓

KNEBV.FI

53.58

-0.11%↓

MTX1

376.6

-0.63%↓

WRT1V.FI

24.37

+1.58%↑

BVI

26.84

+0.9%↑

Search

LISI.

Atidarymo kaina

SektoriusPramonės sektorius

47.2 0.75

Apžvalga

Akcijų kainos pasikeitimas

24 val.

Dabar

Min

46.6

Max

48

Pagrindiniai rodikliai

By Trading Economics

Pajamos

24M

Pardavimai

890M

P/E

Sektoriaus vid.

31.815

42.612

Pelno marža

2.744

Darbuotojai

10,262

EBITDA

102M

Rekomendacijos

By TipRanks

Rekomendacijos

Pirkti

12 mėnesių prognozė

-3.5% downside

Rinkos statistika

By TradingEconomics

Rinkos kapitalizacija

2B

Ankstesnė atidarymo kaina

46.45

Ankstesnė uždarymo kaina

47.2

Naujienos nuotaikos

By Acuity

41%

59%

177 / 461 reitingas Industrials

Techninis įvertinimas

By Trading Central

Pasitikėjimas

Strong Bullish Evidence

LISI. Grafikas

Ankstesni rezultatai nėra patikimas būsimų rezultatų rodiklis.

Susijusios naujienos

2025-08-04 21:42; UTC

Uždarbis
Įsigijimai, susijungimai, perėmimai

Cabot to Acquire Mexico Carbon Manufacturing From Bridgestone

2025-08-04 21:21; UTC

Uždarbis
Pagrindinės rinkos jėgos

Vertex Stock Falls After Pain-Drug Setback, Despite Stronger 2Q Earnings -- Update

2025-08-04 20:45; UTC

Uždarbis

Vertex Pharmaceuticals Swings to 2Q Profit as Sales Climb

2025-08-04 19:15; UTC

Pagrindinės rinkos jėgos

TransMedics Group Shares Rise on FDA Approval for Clinical Trial

2025-08-04 23:41; UTC

Rinkos pokalbiai

Global Forex and Fixed Income Roundup: Market Talk

2025-08-04 23:41; UTC

Rinkos pokalbiai

Nikkei May Rise on Fed Stimulus Hopes

2025-08-04 23:28; UTC

Rinkos pokalbiai

Global Equities Roundup: Market Talk

2025-08-04 23:28; UTC

Rinkos pokalbiai

Gold Seen Stuck in Range as Investors Await Fed's Next Move -- Market Talk

2025-08-04 21:30; UTC

Uždarbis

Palantir Stock Jumps. Earnings Blew Past Wall Street's Expectations. -- Barrons.com

2025-08-04 21:21; UTC

Uždarbis
Įsigijimai, susijungimai, perėmimai

Berkshire Stock Was Hammered Monday. It's Like 1999 Again. -- Barrons.com

2025-08-04 21:18; UTC

Uždarbis

Palantir Stock Jumps. Earnings Blew Past Wall Street's Expectations. -- Barrons.com

2025-08-04 20:25; UTC

Rinkos pokalbiai

India Hits Back Over Russian Oil Purchases -- Market Talk

2025-08-04 20:25; UTC

Uždarbis

Transocean 2Q Loss $938M >RIG

2025-08-04 20:25; UTC

Uždarbis

Transocean 2Q Loss/Shr $1.06 >RIG

2025-08-04 20:18; UTC

Uždarbis

Palantir Stock Jumps. Earnings Blew Past Wall Street's Stratospheric Expectations. -- Barrons.com

2025-08-04 20:15; UTC

Uždarbis

Vertex Pharma: Guidance Includes Immaterial Cost Impact From Tariffs in 2025 Based on Currently Known Tariff Rates and Regulations >VRTX

2025-08-04 20:14; UTC

Uždarbis

Vertex Pharmaceuticals Reiterated FY25 Fincl Guidance >VRTX

2025-08-04 20:14; UTC

Uždarbis

Vertex Pharma: Mark Bunnage, D.Phil., SVP of Global Research, to Assume Role of CSO Effective Feb 1, 2026 >VRTX

2025-08-04 20:14; UTC

Uždarbis

Vertex Pharma: David Altshuler, Chief Scientific Officer, Intends to Retire Aug 1, 2026 >VRTX

2025-08-04 20:13; UTC

Uždarbis

Vertex Pharmaceuticals Backs FY25 Rev $11.85B-$12B >VRTX

2025-08-04 20:09; UTC

Uždarbis

Viper Energy: Initiating Avg Daily Production Guidance for 3Q of 46,000 to 49,000 Bo/d (86,000 to 92,000 Boe/d) >VNOM

2025-08-04 20:06; UTC

Uždarbis

Palantir Earnings Blow Past Wall Street's Stratospheric Expectations -- Barrons.com

2025-08-04 20:01; UTC

Uždarbis

Vertex Pharmaceuticals 2Q Net $1.03B >VRTX

2025-08-04 20:01; UTC

Uždarbis

Vertex Pharmaceuticals 2Q Adj EPS $4.52 >VRTX

2025-08-04 20:01; UTC

Uždarbis

Vertex Pharmaceuticals 2Q Rev $2.96B >VRTX

2025-08-04 20:01; UTC

Uždarbis

Vertex Pharmaceuticals 2Q EPS $3.99 >VRTX

2025-08-04 19:41; UTC

Rinkos pokalbiai

U.S. Natural Gas Futures Settle Lower -- Market Talk

2025-08-04 19:28; UTC

Rinkos pokalbiai

U.S. Hiring Expected to Recover Once Uncertainty Dissipates -- Market Talk

2025-08-04 19:07; UTC

Rinkos pokalbiai

Oil Extends Losing Streak As OPEC+ to Raise Output -- Market Talk

2025-08-04 18:27; UTC

Rinkos pokalbiai

Gold Climbs on Rate Cut Speculation -- Market Talk

Akcijų palyginimas

Kainos pokytis

LISI. Prognozė

Kainos tikslas

By TipRanks

-3.5% į apačią

12 mėnesių prognozė

Vidutinis 45.5 EUR  -3.5%

Aukščiausias 51 EUR

Žemiausias 40 EUR

Remiantis 2 „Wall Street“ analitikais, siūlančiais 12 mėnesių tikslines LISI. kainas – Dist per pastaruosius 3 mėnesius.

Bendras įvertinimas

By TipRanks

Pirkti

2 ratings

2

Pirkti

0

Laikyti

0

Parduoti

Techninis įvertinimas

By Trading Central

27.7 / 28.3Palaikymas ir pasipriešinimas

Trumpalaikis periodas

Strong Bullish Evidence

Vidutinės trukmės periodas

Weak Bullish Evidence

Ilgalaikis periodas

Strong Bullish Evidence

Rinkos nuotaikos

By Acuity

177 / 461 reitingas Pramonės sektorius

Naujienos nuotaikos

Bulių rinkos įrodymas

Svyravimai

Žemiau vidurkio

Naujienų apimtis (RCV)

Aukščiau vidurkio

Finansinės naujienos

Veiklos sąnaudos

Ikimokestinis pelnas

Pardavimai

Pardavimo savikaina

Bendrasis pelnas iš pardavimo

Skolų palūkanų išlaidos

EBITDA

Veiklos pelnas

$

Apie bendrovę LISI.

Lisi S.A. provides assembly and component solutions for the aerospace, automotive, and medical sectors in France and internationally. It operates through three divisions: LISI Aerospace, LISI Automotive, and LISI Medical. The company offers aeronautic fastener solutions; structural components and parts for aircraft, helicopters, and airplanes; air conditioning and pressurization products, actuation and power components, helicopter rotors, landing gear structures, tanks and accumulators, and wheels and brakes; fan blades, outlet guide vanes, compressor blades, fixed vanes, variable vanes, disks, blisks, impellers, gears, inner and outer rings, and housings, as well as accessories and equipment, hot and cold section products for jet engines and turboshafts; and defense and space products. It also provides threaded fasteners, including screws, bolts, nuts, washers, special parts, etc. for industrial and automotive systems; clipped solutions, such as panel and trim fasteners, clipped nuts and screws, fasteners and connectors for cables and tubes, anti-creep rings, etc.; and braking systems, seating, occupant safety systems, fuel system components, etc. In addition, the company offers reconstruction implants and instruments, and spine and orthopedic implants; components and instruments for manual or robotic mini-invasive surgery; and components for laparoscopy, endoscopy, cardiovascular, neuro-cerebral surgery, etc. The company was formerly known as GFI Industries and changed its name to Lisi S.A. in 2002. The company was founded in 1777 and is headquartered in Belfort, France.